| 2023-02-08 | Sale | Cara Therapeutics, Inc. CARA | CHIEF FINANCIAL OFFICER | 5,488 0.0005% | $0.53 | $2,909 | -75.54% | |
| 2022-05-31 | Iovance Biotherapeutics, Inc. IOVA | 7,500 0.0048% | $6.75 | $50,588 | +15.11% | |||
| 2017-11-03 | Sale | Rigel Pharmaceuticals, Inc. RIGL | EVP & CFO | 100,000 0.0697% | $3.90 | $390,000 | -7.47% | |
| 2012-09-12 | Sale | Rigel Pharmaceuticals, Inc. RIGL | EVP & CFO | 23,302 0.0328% | $10.67 | $248,560 | -38.28% | |
| 2012-09-10 | Sale | Rigel Pharmaceuticals, Inc. RIGL | EVP & CFO | 17,586 0.0253% | $10.52 | $184,927 | -35.8% | |
| 2012-09-07 | Sale | Rigel Pharmaceuticals, Inc. RIGL | EVP & CFO | 57,414 0.081% | $10.60 | $608,520 | -37.46% | |
| 2012-08-07 | Sale | Rigel Pharmaceuticals, Inc. RIGL | EVP & CFO | 1,700 0.0024% | $10.61 | $18,041 | -34.63% |